A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
Clinical trial NCT01294800 · COMPLETED
Trial details
- NCT number
- NCT01294800
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-25
- Primary completion
- 2013-06-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.